Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 7, 2017 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
ClinicalTrials.gov Identifier:
NCT00923013
First received: June 17, 2009
Last updated: April 20, 2017
Last verified: February 7, 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 31, 2018
  Estimated Primary Completion Date: December 31, 2018 (Final data collection date for primary outcome measure)